“…Crystal data were collected at the RIAIDT services of the University of Santiago de Compostela on a Bruker SMART-CCD 1000 diffractometer (½PdL 4 2 Á DMSO and ½PtL 5 2 Á 2DMSO) and at the São Carlos Institute of Physics of the University of São Paulo on an Enraf-Nonius CAD-4 diffractometer. Data were corrected for absorption by SADABS [21] (½PdL 4 2 Á DMSO and ½PtL 5 2 Á 2DMSO) or multi-scan [22].…”
“…Data were corrected for absorption by SADABS [21] (½PdL 4 2 Á DMSO and ½PtL 5 2 Á 2DMSO) or multi-scan [22]. The structures were solved using the heavy atom method followed by normal difference Fourier techniques.…”
“…In ½PdL 3 2 the disorder affects the C(16) carbon atom occupying three different positions with occupation factors of 0.35, 0.35 and 0.3, and in this complex there are two independent molecules in the cell. The asymmetric unit of ½PdL 4 2 Á DMSO also includes two molecules of complex and two molecules of DMSO. In the latter the S atoms are disordered in two positions with occupation factors of 0.5 in one case and 0.7 and 0.3 in the other.…”
“…Surprisingly, structural information concerning the 5-pyrazolone complexes with Pd(II) and Pt(II) is rather scarce, although their interaction with palladium has been used in the analysis of the metal [2], in its extraction chemistry [3] and in the preparation of a selective hydrogenation catalyst [4]. According to a structural search of the Cambridge Structural Database (CSD) [5] and a survey of recent literature in SciFinder Ò Scholar, only the Pd(II) derivatives of a phosphoranylidene-substituted pyrazolone [6] and a phosphinopyrazolonate [7] have been prepared and structurally identified by X-ray diffraction.…”
“…Crystal data were collected at the RIAIDT services of the University of Santiago de Compostela on a Bruker SMART-CCD 1000 diffractometer (½PdL 4 2 Á DMSO and ½PtL 5 2 Á 2DMSO) and at the São Carlos Institute of Physics of the University of São Paulo on an Enraf-Nonius CAD-4 diffractometer. Data were corrected for absorption by SADABS [21] (½PdL 4 2 Á DMSO and ½PtL 5 2 Á 2DMSO) or multi-scan [22].…”
“…Data were corrected for absorption by SADABS [21] (½PdL 4 2 Á DMSO and ½PtL 5 2 Á 2DMSO) or multi-scan [22]. The structures were solved using the heavy atom method followed by normal difference Fourier techniques.…”
“…In ½PdL 3 2 the disorder affects the C(16) carbon atom occupying three different positions with occupation factors of 0.35, 0.35 and 0.3, and in this complex there are two independent molecules in the cell. The asymmetric unit of ½PdL 4 2 Á DMSO also includes two molecules of complex and two molecules of DMSO. In the latter the S atoms are disordered in two positions with occupation factors of 0.5 in one case and 0.7 and 0.3 in the other.…”
“…Surprisingly, structural information concerning the 5-pyrazolone complexes with Pd(II) and Pt(II) is rather scarce, although their interaction with palladium has been used in the analysis of the metal [2], in its extraction chemistry [3] and in the preparation of a selective hydrogenation catalyst [4]. According to a structural search of the Cambridge Structural Database (CSD) [5] and a survey of recent literature in SciFinder Ò Scholar, only the Pd(II) derivatives of a phosphoranylidene-substituted pyrazolone [6] and a phosphinopyrazolonate [7] have been prepared and structurally identified by X-ray diffraction.…”
“…58 A mild hydrogenation of nitro aromatics, in the presence of γ-Al 2 O 3 supported palladium()-pyrazol-5-one complexes, has been reported to give anilines in 95-98% yield. 59 Nitrobenzenes have also been chemoselectively reduced to anilines using decaborane in the presence of palladium on carbon and a trace amount of acetic acid and methanol at reflux in 81-97% yield. 60…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.